As a precautionary measure, the Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class one recall of Oxybutynin Hydrochloride.
The Oxybutynin Hydrochloride is used to treat urinary incontinence and other bladder conditions and is commonly prescribed to children with an uncontrollable nocturnal bladder or elderly people with bladder control problems.
MHRA is recalling four batches of 5mg tablets; according to the agency these batches might contain high levels of an active ingredient.
The affected batch numbers are 09D02, 09D04, 146401 and 146402.
The findings were made during the early stages of the drug’s production and to be on the safe side, the MHRA decided to recall these batches while an investigation takes place.
Bladder control problems affect both men and women, but the causes usually differ. In most cases women develop incontinence when pelvic floor muscles, muscles that support the bladder, weaken. Sometimes after giving birth women can experience this problem, pelvic muscle exercises can help improve the situations, in some cases medication or surgery is needed.
For men, the problem is slightly different, the prostate gland enlarges as men age and presses on the bladder, squeezing the urethra and inhibiting urine to pass, in these individuals it is common to retain urine in the bladder even after urination. The retained urine can increase and stretch the bladder causing damage to muscles that control the bladder as well as the kidneys.
Men and women have similar incontinence symptoms but different treatments. In some cases urinary incontinence signals a larger health problem, so don’t be ashamed to talk to your doctor, only he or she can help you regain control of your bladder and diagnose any other health issue you might have.